Must Say I had feeling a sales drop because of current COVID environment Must say its killing us over here business involvement here is dead been dead for last 15 months
Asia was a ouch
Domestically is up ( how much in % would be nice to know )
Discussions with interested distributors, wholesalers and retailers continue in Thailand, China and Japan, as well as retailers in the United Kingdom and Europe.
Well is above true lets hope
Research Prof Michael Barnett is an Australian-based health professional. Michael is trained as a Neurologist (Brain Specialist) and has a practice located in Camperdown. Special interests General neurology including central neuro immunology with a focus on Multiple Sclerosis, neuro-op htalmology and neuro physiology.
Canntab lets all see At December 2020 the number of Authorised Prescribers was less than 50, at the end of the quarter it was 179. Cann Global is well positioned to take advantage of increased patient and prescriber numbers with the imminent launch of its Canntab product.
Willing to say nothing bad give them until 29/10/21 that s 6 months
zess If Michael Barnett, is willing to help NICM with this project. He has read the Technion report based on in vitro and in vivo, to assist in the recovery , and to stop the progression of, the auto immune disease Multiple Sclerosis.
Who knows we all could be blown away if above stacks up Michael Barnett is willing !! he likes the reports
CGB Price at posting:
0.7¢ Sentiment: Buy Disclosure: Held